The Senate confirmed Jim O'Neill, former CEO of SENS Research Foundation, as deputy secretary at the Department of Health and Human Services.

The Trump administration’s cancellation of $766 million in contracts to develop mRNA vaccines against potential pandemic flu ...

Pakistan has the intellectual capital, institutional foundation and market potential to achieve vaccine independence. What we ...

The Trump administration’s cancellation of $766 million in contracts to develop mRNA vaccines against potential pandemic flu ...

In a recent Q&A hosted by Susan Thornton, CEO of the Cutaneous Lymphoma Foundation, a patient advocacy group, Dr. Kim shared her gratitude to clinical trial participants and emphasized the urgent need ...

The new head of Anthony Fauci’s former institute has accrued an extraordinary amount of research money and power in recent ...

Despite positive results from a Phase I/II trial of its investigational pandemic influenza vaccine, mRNA-1018, Moderna’s ...

Soligenix (NASDAQ: SNGX) is spotlighting new interim data on HyBryte(TM) (synthetic hypericin) for early-stage cutaneous T-cell ly ...

Press release Launch of a capital increase with preferential subscription rights for nearly 5 million euros Issuance of new shares for an initial total amount of around €5.0 million, with shareholders ...

Moderna had already started a Phase 1/2 trial of its bird flu (H5N1) vaccine and reported strong early results.

There’s one area of surprising agreement in the often adversarial relationship between conservatives and the scientific ...